Cellivate Technologies Secures $1 Million in Seed Funding to Revolutionize Cell Culture and Biomanufacturing

Date:

Biotech startup Cellivate Technologies has successfully raised $1 million in its seed funding round, led by Antler and supported by Venture Catalysts, Hatcher+, and We Founder Circle.

The funding will be directed towards advancing research and development, scaling up production of its pioneering products, and expanding its market presence. Founded by Viknish Krishnan Kutty, Cellivate Technologies is focused on overcoming significant challenges in cell culture and biomanufacturing.

The company’s flagship innovations include cutting-edge microcarriers designed to enhance cell growth scalability and a novel cell-based serum that aims to replace traditional fetal bovine serum. These advancements address both efficiency and ethical concerns in cell culture processes.

Market analysis predicts that the cell culture market, including microcarriers and serum, will reach $33 billion by 2030. Cellivate Technologies’ solutions are poised to reduce costs, enhance efficiency, and minimize reliance on animal-derived products, contributing to a more sustainable and ethical biomanufacturing landscape.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

7 Steps to Set Up Your Business for Financial Success in 2025

Whether you’re launching your business in 2025, or hoping...

Why Effective Digital Identity Management is Critical for Brand Growth

The digital disruption has fundamentally changed the way customers...

Inc. celebrates entrepreneurship with 2024 Best in Business Awards

On average, 4.7 million new businesses are created in...

Top Tips For Starting A Business From Your Sofa In 2025

According to a recent study, around 40% of Americans...